Lingdian Wang

机构：Dalian Medical University, Henan Provincial People's Hospital, First Affiliated Hospital of Dalian Medical University

发表论文 13 篇 · 总被引 48 次 · h-index 4

代表论文

• Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma (2023 · Journal of Cancer Research and Clinical Oncology · 被引 10)
• LncRNA PGM5-AS1 Inhibits the Progression of Bladder Cancer by Regulating miR-587/SLIT3 Axis (2022 · Critical Reviews in Eukaryotic Gene Expression · 被引 7)
• A urine-based liquid biopsy for detection of upper tract urothelial carcinoma: a self-matched study (2024 · BMC Cancer · 被引 6)
• Segmental ureterectomy for high-risk ureteral carcinoma: a preliminary report (2023 · BMC Urology · 被引 5)
• Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy (2022 · Journal of Immunology Research · 被引 4)
• A urine DNA methylation assay for early detection of renal cancer (2025 · Oncogene · 被引 3)